News

The company has entered into an option agreement to exclusively license worldwide rights to a panel of fully human monoclonal antibodies targeting the SIRPa protein (CD172a).

The appointment of Michael A. Luther, Ph.D. as Senior Vice President of Discovery sees AMRI expanding its biology capabilities.

The companies to develop offering that combines Whole Genome Mapping™ with cloud-based informatics and data management platforms.

The fast track program selects first cohort of 25 high-growth businesses to help accelerate their growth.

Memorandum of Understanding between the two companies will identify reciprocal consultation and manufacturing opportunities for clients in Japan and Europe whilst enabling joint collaborative development in the US.

The patent relates to the method by which induced pluripotent stem cells are differentiated into the diverse types of endothelial and hematopoietic cells.

New Centre of Excellence extends Pall’s local capabilities in the region.

The substance, N,alpha-diethylphenylethylamine, has a structure similar to methamphetamine and was found in a consumer dietary supplement product called Craze.

Sessions are free to all registered attendees, providing an informal venue for participants to openly discuss topics of mutual interest or solve problems specific to certain instrumentation or procedures.

Enhancements in high potency chromatography and Kilo-Lab.